Skip to main content
. 2021 Aug 6;13(16):3963. doi: 10.3390/cancers13163963

Figure 7.

Figure 7

Association of glutaminase expression with patient outcome in ER +/HER2- invasive breast cancer in the METABRIC and Nottingham series: breast cancer-specific survival of (a) GLS copy number gain, (b) GLS2 copy number gain, (c) GLS mRNA, (d) GLS2 mRNA, (e) GLS protein and (f) GLS2 protein, a disease-free interval of (g) GLS protein and (h) GLS2 protein. Statistically significant p values are in bold.